Institutional Ownership
Context Therapeutics Inc
CUSIP 21077P108COMCNTXQ1 2026
Institutional Holders
56
13F filers
Shares Held
70.39M
Aggregate institutional
Institutional Value
$184.07M
Q1 2026
Net New Holders
+16
22 new · 6 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions22
Increased10
Decreased13
Sold out6
Institutional Holders
56 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Mpm Bioimpact LLC | 10.68M | $27.98M | 0 | Held |
| 2 | Nextech Invest, Ltd. | 7.42M | $19.44M | 0 | Held |
| 3 | Deep Track Capital, LP | 7.42M | $19.44M | 0 | Held |
| 4 | Soleus Capital Management, L.P. | 6.96M | $18.24M | +6.96M | New |
| 5 | Octagon Capital Advisors LP | 5.25M | $13.76M | +5.25M | New |
| 6 | Blue Owl Capital Holdings LP | 5.09M | $13.33M | −2.34M | Reduced |
| 7 | Avidity Partners Management LP | 5.00M | $13.10M | −506.6K | Reduced |
| 8 | Franklin Resources Inc | 3.80M | $9.96M | −200.0K | Reduced |
| 9 | Marshall Wace, LLP | 2.95M | $7.72M | +355.2K | Added |
| 10 | Tcg Crossover Management, LLC | 2.68M | $7.03M | +2.68M | New |
46 more institutional holders on Premium
See every fund holding Context Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders